or Try an Advanced Search...

    Technical Analysis for GMDA - Gamida Cell Ltd.

    Grade Last Price % Change Price Change
    F 0.02 -43.73% -0.01
    GMDA closed down 43.73 percent on Friday, April 26, 2024, on 6 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical GMDA trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Gilligan's Island Buy Setup Bullish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish -43.73%
    Narrow Range Bar Range Contraction -43.73%
    Older End-of-Day Signals for GMDA ...

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    GMDA Chart by TradingView
    Basic chart:

    Profile

    Gamida Cell is a clinical stage biopharmaceutical company leveraging its proprietary technology to develop cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The company is leveraging its nicotinamide-, or NAM-, based cell expansion technology to develop a pipeline of products designed to address the limitations of cell therapies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Cyclacel Rare Serious Hematologic Diseases

    Is GMDA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 8 XORTX Welcomes New Member to the Board of Directors
    Apr 3 Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Apr 1 Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
    Mar 28 Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
    Mar 28 Q4 2023 Gamida Cell Ltd Earnings Call
    Mar 27 Gold Moves Higher; Velo3D Shares Plummet
    Mar 27 Gamida Cell Ltd. (GMDA) Q4 2023 Earnings Call Transcript
    Mar 27 Gamida Cell starts restructuring process supported by Highbridge Capital, stock down
    Mar 27 Gamida Cell GAAP EPS of -$0.57 misses by $0.42, revenue of $1.78M beats by $0.72M
    Mar 27 Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
    See more GMDA news...

    Comments

    S

    SociableGnat503 9 months ago

    Any thoughts on this one? It's insane of how much this has bled over the past several weeks. 

    0 Reply
    T

    TraderMike 9 months ago

    My only thoughts are this seems to be a small biotech doing what small biotechs do.  These things are incredibly news driven, especially the clinical stage ones.

    1 Reply
    S

    SociableGnat503 9 months ago

    They have an earnings call on Monday and onboarding and sales will likely determine where it goes in the future.  

    0 Reply
    S

    SociableGnat503 9 months ago

    Looks like it has a bullish pattern although this thing has been manipulated for so long that it's impossible to ascertain of how reliable the signal is.  Hoping for the best on this one! 

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.51
    52 Week Low 0.0155
    Average Volume 10,823,262
    200-Day Moving Average 0.75
    50-Day Moving Average 0.31
    20-Day Moving Average 0.23
    10-Day Moving Average 0.10
    Average True Range 0.04
    RSI (14) 21.88
    ADX 31.11
    +DI 14.55
    -DI 46.64
    Chandelier Exit (Long, 3 ATRs) 0.30
    Chandelier Exit (Short, 3 ATRs) 0.13
    Upper Bollinger Bands 0.54
    Lower Bollinger Band -0.09
    Percent B (%b) 0.17
    BandWidth 274.56
    MACD Line -0.09
    MACD Signal Line -0.06
    MACD Histogram -0.0267
    Fundamentals Value
    Market Cap 2.44 Million
    Num Shares 133 Million
    EPS -0.82
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 75.50
    Price-to-Book 132.85
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.02
    Resistance 3 (R3) 0.02 0.02 0.02
    Resistance 2 (R2) 0.02 0.02 0.02 0.02
    Resistance 1 (R1) 0.02 0.02 0.02 0.02 0.02
    Pivot Point 0.02 0.02 0.02 0.02 0.02
    Support 1 (S1) 0.02 0.02 0.02 0.02 0.01
    Support 2 (S2) 0.01 0.02 0.01 0.01
    Support 3 (S3) 0.01 0.01 0.01
    Support 4 (S4) 0.01